Mpox outbreak compounds crisis in conflict-hit eastern Congo
Medics in eastern Congo battle an ongoing Mpox outbreak while the region's chronic instability complicates public health ...
Congo faces setback in mpox response after Rwanda-backed rebels advance in the east
Six weeks after Rwanda-backed rebels captured the eastern Congolese cities of Goma and Bukavu, the region is facing a setback ...
DR Congo battles mpox epidemic amid conflict in the east
Nurses are administering medicine to Mpox patients at a tent in Kabare, Democratic Republic of the Congo, as the area ...
Tecovirimat is safe but ineffective as treatment for clade II mpox
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...
The EastAfrican on MSN2h
Tanzania declares Marburg outbreak over, issues Mpox alert
Health Minister Jenista Mhagama declared Marburg after six weeks since the last case in ...
Sierra Sun Times1d
NIH Reports Tecovirimat is Safe But Ineffective as Treatment for Clade II Mpox
NIH-sponsored trial data offers further evidence to help inform mpox treatment decisions.
Tanzania reports first mpox case
Tanzania has confirmed its first two cases of mpox, the health ministry said Monday, the first time the virus has been ...
Mpox: Warning over ‘highly infectious’ new variant identified in Congo
A new mutated variant of Mpox has been identified in Democratic Republic of Congo, with health authorities concerned over ...
NIH Trial Finds Tecovirimat Ineffective As Monotherapy For Mpox
A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024, with findings presented at CROI 2025.
Mpox still a health emergency, says WHO
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...